Australia Plans Stronger Panel To Oversee Approved Drugs
This article was originally published in PharmAsia News
Executive Summary
The Australian government is considering replacing its Adverse Drug Reactions Advisory Committee in charge of drug safety with a Medicines Safety Committee. The intent is to overhaul the nation's system for ensuring drug safety. The new agency is expected to be given the authority for rigorous surveillance of prescription drugs that have passed the country's approval process. Other changes planned include drug audits and appointment of a drug monitor for checking the safety of specific drugs. The Medicines Safety Committee also would have greater oversight authority of risk-management plans of makers of approved drug products. (Click here for more